KDM biological age, PhenoAge and homeostatic dysregulation

Biomarker

1 paper mentions it4 findings

See all 1 papers on KDM biological age, PhenoAge and homeostatic dysregulation

“Advanced BA quantified by clinical biomarkers is associated with increased risks of any cancer, lung cancer, and colorectal cancer.”
Clinical biomarker-based biological aging and risk of cancer in the UK BiobankBritish journal of cancer2023doi:10.1038/s41416-023-02288-w

Associations

4

Prostate cancer incidence

downin humans1

1 study
  1. KDM biological age, PhenoAge and homeostatic dysregulation is associated with prostate cancer incidence in humans.

    “Furthermore, we observed an inverse association between BA measures and prostate cancer”

    HumansAssociation attenuated after removing glycated hemoglobin and serum glucose from the biological age algorithmsMedian follow-up of 10.9 years

    Clinical biomarker-based biological aging and risk of cancer in the UK Biobank

    British journal of cancer

More on Prostate cancer incidence

Colorectal cancer incidence

upin humans1

1 study
  1. KDM biological age, PhenoAge and homeostatic dysregulation is associated with colorectal cancer incidence in humans (No history of cancer at enrolment).

    “All BA measures were also associated with increased risks of lung and colorectal cancers, but only PhenoAge was associated with breast cancer risk.”

    HumansNo history of cancer at enrolmentMedian follow-up of 10.9 yearsn = 308,156

    Clinical biomarker-based biological aging and risk of cancer in the UK Biobank

    British journal of cancer

More on Colorectal cancer incidence

Lung cancer incidence

upin humans1

1 study
  1. KDM biological age, PhenoAge and homeostatic dysregulation is associated with lung cancer incidence in humans (No history of cancer at enrolment).

    “All BA measures were also associated with increased risks of lung and colorectal cancers, but only PhenoAge was associated with breast cancer risk.”

    HumansNo history of cancer at enrolmentMedian follow-up of 10.9 yearsn = 308,156

    Clinical biomarker-based biological aging and risk of cancer in the UK Biobank

    British journal of cancer

More on Lung cancer incidence

Cancer incidence

upin humans1HR 1.04

1 study
  1. KDM biological age, PhenoAge and homeostatic dysregulation is associated with cancer incidence in humans (No history of cancer at enrolment; adjusted for common cancer risk factors) (Per SD: age-adjusted KDM HR 1.04 (95% CI 1.03–1.05); age-adjusted PhenoAge HR 1.09 (1.07–1.10); HD HR 1.02 (1.01–1.03)).

    “Advanced BA quantified by clinical biomarkers is associated with increased risks of any cancer, lung cancer, and colorectal cancer.”

    HumansNo history of cancer at enrolment; adjusted for common cancer risk factors1-standard deviation incrementMedian follow-up of 10.9 yearsn = 308,156

    Clinical biomarker-based biological aging and risk of cancer in the UK Biobank

    British journal of cancer

More on Cancer incidence

Latest